^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    lucatumumab (CHIR 12.12)

    i
    Other names: HCD 122, CHIR 12.12
    Associations
    News
    Trials
    Company:
    Novartis, Xoma
    Drug class:
    CD40 inhibitor
    Related drugs:
    Associations
    News
    Trials